Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19.

Naci H., Kesselheim AS., Røttingen J-A., Salanti G., Vandvik PO., Cipriani A.

DOI

10.1136/bmj.m3869

Type

Journal article

Journal

BMJ

Publication Date

16/10/2020

Volume

371

Keywords

Betacoronavirus, COVID-19, Comparative Effectiveness Research, Coronavirus Infections, Drug Development, Ethics, Research, Evidence-Based Medicine, Humans, International Cooperation, Pandemics, Pneumonia, Viral, Quality Improvement, Randomized Controlled Trials as Topic, Research Design, SARS-CoV-2, Translational Medical Research

Permalink Original publication